In the context of COVID-19, the CCR5-CCL5 axis may play a role in the immunopathogenesis of severe cases, and there is theoretical evidence that targeting this pathway could be advantageous in the context of respiratory viral infection. The gene discussed is CCR5; the disease is COVID-19.